Literature DB >> 32329219

A simplified method for the efficient purification and refolding of recombinant human TRAIL.

Zhenjiang Zhang1, Su Bin Hahn1, Thong M Cao1, Michael R King1.   

Abstract

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) belongs to the TNF cytokine superfamily that specifically induces apoptosis in a broad spectrum of human cancer cell lines but not in most healthy cells. The antitumor potential of recombinant human TRAIL (rhTRAIL) has attracted great attention among biologists and oncologists. However, attempts to express rhTRAIL in Escherichia coli often results in limited yield of bioactive protein due to the formation of inclusion bodies (IBs), which are dense insoluble particulate protein aggregates inside cells. We describe herein a highly simplified method to produce pure bioactive rhTRAIL using E. coli. The method is straightforward and requires only basic laboratory equipment, with highly efficient purification and high yield of renaturation, and may also be applied to produce other proteins that form IBs in E. coli.
© 2020 American Institute of Chemical Engineers.

Entities:  

Keywords:  TRAIL; protein expression; protein refolding; recombinant protein

Year:  2020        PMID: 32329219      PMCID: PMC7572648          DOI: 10.1002/btpr.3007

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  35 in total

1.  Refolding and purification of Apo2l/TRAIL produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.

Authors:  Ya-Ling Shen; Xiao-Xia Xia; Yue Zhang; Jian-Wen Liu; Dong-Zhi Wei; Sheng-Li Yang
Journal:  Biotechnol Lett       Date:  2003-12       Impact factor: 2.461

Review 2.  Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.

Authors:  Lisa D Cabrita; Stephen P Bottomley
Journal:  Biotechnol Annu Rev       Date:  2004

3.  Expression, purification and crystallization of recombinant human TRAIL.

Authors:  S S Cha; H C Shin; K Y Choi; B H Oh
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-05

4.  Inducing rigid local structure around the zinc-binding region by hydrophobic interactions enhances the homotrimerization and apoptotic activity of zinc-free TRAIL.

Authors:  Hyun-Wook Lee; Tae-In Kim; Khon Huynh Chan; Myung-Hee Kwon; Jeong-Sun Kim; Moonsoo Jin; Yong-Sung Kim
Journal:  Biochem Biophys Res Commun       Date:  2007-08-24       Impact factor: 3.575

5.  L-Arginine increases the solubility of unfolded species of hen egg white lysozyme.

Authors:  Ravi Charan Reddy K; Hauke Lilie; Rainer Rudolph; Christian Lange
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

6.  Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Authors:  Zhihua Lin; Huanzong Lei; Peng Cao
Journal:  Protein Expr Purif       Date:  2006-08-15       Impact factor: 1.650

Review 7.  Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.

Authors:  Pedro P G Guimarães; Stephanie Gaglione; Tomasz Sewastianik; Ruben D Carrasco; Robert Langer; Michael J Mitchell
Journal:  ACS Nano       Date:  2018-02-06       Impact factor: 15.881

8.  Fed-batch production of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in soluble form in Escherichia coli and its purification and characterization.

Authors:  Ping Li; Qing Gu; Xuechang Wu
Journal:  Protein Expr Purif       Date:  2016-06-19       Impact factor: 1.650

9.  Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection.

Authors:  Nidhi Jyotsana; Zhenjiang Zhang; Lauren E Himmel; Fang Yu; Michael R King
Journal:  Sci Adv       Date:  2019-07-24       Impact factor: 14.136

Review 10.  Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.

Authors:  Hiroshi Yamaguchi; Masaya Miyazaki
Journal:  Biomolecules       Date:  2014-02-20
View more
  1 in total

1.  TRAIL/S-layer/graphene quantum dot nanohybrid enhanced stability and anticancer activity of TRAIL on colon cancer cells.

Authors:  Shima Lotfollahzadeh; Elaheh Sadat Hosseini; Hooman Mahmoudi Aznaveh; Maryam Nikkhah; Saman Hosseinkhani
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.